Life science tools and diagnostics provider Bio-Techne Corporation has officially opened a state-of-the-art, purpose-built manufacturing facility in Bristol, United Kingdom,…
Read More
Roche Secures FDA Approval for Tecentriq in Stage III dMMR Colon Cancer Setting to Establish New Treatment Paradigm
The pharmaceutical landscape for gastrointestinal oncology has undergone a significant transformation following a landmark regulatory decision by the US Food…
Read More
AI-Driven Oncology Pioneer Iambic Therapeutics Targets $135m Nasdaq IPO in Banner Year for Biotech Listings
Iambic Therapeutics, an oncology-focused biotechnology company recognized for its pioneering intersection of artificial intelligence and drug discovery, has officially set…
Read More
Viatris Expands Into Non-Opioid Pain Market With $1.65bn Acquisition of Pacira BioSciences
The global pharmaceutical landscape is undergoing a profound structural shift as healthcare enterprises aggressively pivot away from traditional opioid-based narcotics…
Read More
WHO Issues Landmark Global Guidelines Urging Lifestyle Interventions Over Weight Loss Drugs for Pediatric Obesity
The World Health Organization (WHO) has released its first-ever comprehensive global guidelines addressing child and adolescent obesity, establishing a clear…
Read More
Suspected Plague Outbreak in Russia Public Health Risk Lower Than Covid-19
Global health authorities and epidemiological experts have closely monitored developments surrounding a suspected plague outbreak in Russia, with initial risk…
Read More
KymaThera pulls in $80m to bring breast cancer drug to clinic – Pharmaceutical Technology
San Diego-based biopharmaceutical company KymaThera has successfully closed an $80 million Series B financing round to propel its lead oncology…
Read More
Roche Acquires Global Rights to Alector’s Parkinson’s Disease Candidate AL050 in Landmark $1.27bn Deal
Swiss pharmaceutical giant Roche has secured global rights to Alector’s prominent preclinical Parkinson’s disease candidate, AL050, in a lucrative transaction…
Read More
Eli Lilly Expands Multi-Million Dollar Biotech Partnership with Gate Bioscience to Pioneer ‘Molecular Gate’ Therapies for Hard-to-Drug Proteins
Eli Lilly and Company has significantly deepened its footprint in cutting-edge drug discovery by expanding its strategic partnership and licensing…
Read More
Shionogi Expands Rare Disease Portfolio With $2 Billion Acquisition of IntraBio and Flagship Drug Aqneursa
Japanese pharmaceutical major Shionogi has announced a definitive agreement to acquire IntraBio in a multibillion-dollar transaction valued at $2 billion.…
Read MoreYOU MAY HAVE MISSED
